Nouveau Life Pharmaceuticals, Inc. (Nouveau Life Pharmaceuticals, I) Aktie
NOUV
GeschlossenNouveau Life Pharmaceuticals, I
Market Cap
$666,096
Über Nouveau Life Pharmaceuticals, Inc. (Nouveau Life Pharmaceuticals, I) Aktie
Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in providing a platform for remote senior care. The company also enables users to monitor patients in real time and access detailed patient information digitally; and its platform is designed to detect emergencies proactively and facilitate non-face-to-face care services. In addition, the company is developing robotic and artificial intelligence (AI)-based healthcare devices and wearables. The company was formerly known as Gondwana Energy, Ltd. and changed its name to Nouveau Life Pharmaceuticals, Inc. in May 1998. The company was incorporated in 1998 and is based in Los Angeles, California. Nouveau Life Pharmaceuticals, Inc. operates as a subsidiary of Seniorgo.ai.
Unternehmensinformationen
90010 Los Angeles, United States
Analystenempfehlungen
Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.